AEMD
Price
$1.25
Change
-$0.69 (-35.57%)
Updated
Jun 27 closing price
Capitalization
4.4M
APDN
Price
$4.83
Change
+$0.32 (+7.10%)
Updated
Jun 27 closing price
Capitalization
7.13M
Interact to see
Advertisement

AEMD vs APDN

Header iconAEMD vs APDN Comparison
Open Charts AEMD vs APDNBanner chart's image
Aethlon Medical
Price$1.25
Change-$0.69 (-35.57%)
Volume$1.03M
Capitalization4.4M
Applied DNA Sciences
Price$4.83
Change+$0.32 (+7.10%)
Volume$49.37K
Capitalization7.13M
AEMD vs APDN Comparison Chart in %
Loading...
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AEMD vs. APDN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a Buy and APDN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (AEMD: $1.25 vs. APDN: $4.83)
Brand notoriety: AEMD and APDN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AEMD: 823% vs. APDN: 58%
Market capitalization -- AEMD: $4.4M vs. APDN: $7.13M
AEMD [@Medical Specialties] is valued at $4.4M. APDN’s [@Medical Specialties] market capitalization is $7.13M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEMD’s FA Score shows that 1 FA rating(s) are green whileAPDN’s FA Score has 1 green FA rating(s).

  • AEMD’s FA Score: 1 green, 4 red.
  • APDN’s FA Score: 1 green, 4 red.
According to our system of comparison, both AEMD and APDN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEMD’s TA Score shows that 3 TA indicator(s) are bullish while APDN’s TA Score has 3 bullish TA indicator(s).

  • AEMD’s TA Score: 3 bullish, 6 bearish.
  • APDN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, APDN is a better buy in the short-term than AEMD.

Price Growth

AEMD (@Medical Specialties) experienced а -20.89% price change this week, while APDN (@Medical Specialties) price change was -8.70% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.14%. For the same industry, the average monthly price growth was +1.17%, and the average quarterly price growth was -0.01%.

Industries' Descriptions

@Medical Specialties (+1.14% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APDN($7.13M) has a higher market cap than AEMD($4.4M). AEMD YTD gains are higher at: -81.831 vs. APDN (-96.843). APDN (-12.2M) and AEMD (-12.28M) have comparable annual earnings (EBITDA) . AEMD has more cash in the bank: 7.97M vs. APDN (3.36M). AEMD has less debt than APDN: AEMD (1.01M) vs APDN (1.12M). APDN has higher revenues than AEMD: APDN (9M) vs AEMD (574K).
AEMDAPDNAEMD / APDN
Capitalization4.4M7.13M62%
EBITDA-12.28M-12.2M101%
Gain YTD-81.831-96.84384%
P/E RatioN/AN/A-
Revenue574K9M6%
Total Cash7.97M3.36M237%
Total Debt1.01M1.12M90%
FUNDAMENTALS RATINGS
AEMD vs APDN: Fundamental Ratings
AEMD
APDN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9898
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APDN's Valuation (25) in the Information Technology Services industry is in the same range as AEMD (27) in the Medical Specialties industry. This means that APDN’s stock grew similarly to AEMD’s over the last 12 months.

APDN's Profit vs Risk Rating (100) in the Information Technology Services industry is in the same range as AEMD (100) in the Medical Specialties industry. This means that APDN’s stock grew similarly to AEMD’s over the last 12 months.

AEMD's SMR Rating (99) in the Medical Specialties industry is in the same range as APDN (100) in the Information Technology Services industry. This means that AEMD’s stock grew similarly to APDN’s over the last 12 months.

AEMD's Price Growth Rating (98) in the Medical Specialties industry is in the same range as APDN (98) in the Information Technology Services industry. This means that AEMD’s stock grew similarly to APDN’s over the last 12 months.

APDN's P/E Growth Rating (93) in the Information Technology Services industry is in the same range as AEMD (100) in the Medical Specialties industry. This means that APDN’s stock grew similarly to AEMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEMDAPDN
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
67%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AEMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VMAR7.210.57
+8.58%
Vision Marine Technologies Inc
SFBC46.81N/A
N/A
Sound Financial Bancorp
AMLX6.50N/A
N/A
Amylyx Pharmaceuticals
FLG10.81-0.19
-1.73%
Flagstar Financial Inc
SMMT20.60-0.72
-3.38%
Summit Therapeutics

AEMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, AEMD has been loosely correlated with ISPC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AEMD jumps, then ISPC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEMD
1D Price
Change %
AEMD100%
-35.57%
ISPC - AEMD
35%
Loosely correlated
-2.83%
APDN - AEMD
27%
Poorly correlated
+6.98%
HSDT - AEMD
24%
Poorly correlated
-37.92%
RBOT - AEMD
24%
Poorly correlated
-1.68%
INMD - AEMD
23%
Poorly correlated
N/A
More

APDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, APDN has been closely correlated with BNR. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if APDN jumps, then BNR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APDN
1D Price
Change %
APDN100%
+6.98%
BNR - APDN
85%
Closely correlated
-10.26%
SINT - APDN
84%
Closely correlated
+1.90%
SSKN - APDN
80%
Closely correlated
-3.85%
GCTK - APDN
72%
Closely correlated
+25.67%
AIMD - APDN
38%
Loosely correlated
+3.69%
More